top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Entry threats and pricing in the generic drug industry [[electronic resource] /] / Brett Wendling, Steven Tenn
Entry threats and pricing in the generic drug industry [[electronic resource] /] / Brett Wendling, Steven Tenn
Autore Wendling Brett
Pubbl/distr/stampa Washington, DC : , : Bureau of Economics, Federal Trade Commission, , [2010]
Descrizione fisica 1 online resource (27 pages) : digital, PDF file
Altri autori (Persone) TennSteven
Collana Working paper
Soggetto topico Generic drugs - Prices - United States
Pharmaceutical industry - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910699567003321
Wendling Brett  
Washington, DC : , : Bureau of Economics, Federal Trade Commission, , [2010]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2018
Descrizione fisica 1 online resource (iii, 43 pages) : illustrations
Collana S. hrg.
Soggetto topico Prescription pricing - United States
Drugs - Law and legislation - United States
Pharmaceutical industry - United States
Competition - United States
Drug delivery devices - Prices - United States
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti EpiPen price increases
Record Nr. UNINA-9910711623503321
Washington : , : U.S. Government Publishing Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Establishing a CGMP laboratory audit system [[electronic resource] ] : a practical guide / / David M. Bliesner
Establishing a CGMP laboratory audit system [[electronic resource] ] : a practical guide / / David M. Bliesner
Autore Bliesner David M
Pubbl/distr/stampa Hoboken, N.J., : Wiley-Interscience, c2006
Descrizione fisica 1 online resource (295 p.)
Disciplina 343.7307/86151
542.1
Soggetto topico Pharmaceutical industry - United States
Drugs - Law and legislation - United States
Soggetto genere / forma Electronic books.
Soggetto non controllato Current Good Manufacturing Practices
ISBN 1-280-44808-3
9786610448081
0-470-23938-7
0-471-78478-8
0-471-78477-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Preface -- Introduction to the quality systems approach to CGMP compliance -- Preparing for the audit -- Auditing and data capture -- Organizing data and reporting the results -- Developing and implementing a corrective action plan -- Developing and implementing a verification plan -- Developing and implementing a monitoring plan -- A summary for establishing a CGMP laboratory audit system -- Appendixes -- Example audit checklists: laboratory subelements -- Example template for an audit summary report -- Glossary of CGMP and audit system terms -- FDA compliance program guidance manual 7356.002 "Drug manufacturing inspections" -- 21 Code of U.S Federal Regulations parts 210 and 211 current good manufacturing practice regulations.
Record Nr. UNINA-9910143411103321
Bliesner David M  
Hoboken, N.J., : Wiley-Interscience, c2006
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Establishing a CGMP laboratory audit system [[electronic resource] ] : a practical guide / / David M. Bliesner
Establishing a CGMP laboratory audit system [[electronic resource] ] : a practical guide / / David M. Bliesner
Autore Bliesner David M
Pubbl/distr/stampa Hoboken, N.J., : Wiley-Interscience, c2006
Descrizione fisica 1 online resource (295 p.)
Disciplina 343.7307/86151
542.1
Soggetto topico Pharmaceutical industry - United States
Drugs - Law and legislation - United States
Soggetto non controllato Current Good Manufacturing Practices
ISBN 1-280-44808-3
9786610448081
0-470-23938-7
0-471-78478-8
0-471-78477-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Preface -- Introduction to the quality systems approach to CGMP compliance -- Preparing for the audit -- Auditing and data capture -- Organizing data and reporting the results -- Developing and implementing a corrective action plan -- Developing and implementing a verification plan -- Developing and implementing a monitoring plan -- A summary for establishing a CGMP laboratory audit system -- Appendixes -- Example audit checklists: laboratory subelements -- Example template for an audit summary report -- Glossary of CGMP and audit system terms -- FDA compliance program guidance manual 7356.002 "Drug manufacturing inspections" -- 21 Code of U.S Federal Regulations parts 210 and 211 current good manufacturing practice regulations.
Record Nr. UNINA-9910830871703321
Bliesner David M  
Hoboken, N.J., : Wiley-Interscience, c2006
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Establishing a CGMP laboratory audit system [[electronic resource] ] : a practical guide / / David M. Bliesner
Establishing a CGMP laboratory audit system [[electronic resource] ] : a practical guide / / David M. Bliesner
Autore Bliesner David M
Pubbl/distr/stampa Hoboken, N.J., : Wiley-Interscience, c2006
Descrizione fisica 1 online resource (295 p.)
Disciplina 343.7307/86151
542.1
Soggetto topico Pharmaceutical industry - United States
Drugs - Law and legislation - United States
Soggetto non controllato Current Good Manufacturing Practices
ISBN 1-280-44808-3
9786610448081
0-470-23938-7
0-471-78478-8
0-471-78477-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Preface -- Introduction to the quality systems approach to CGMP compliance -- Preparing for the audit -- Auditing and data capture -- Organizing data and reporting the results -- Developing and implementing a corrective action plan -- Developing and implementing a verification plan -- Developing and implementing a monitoring plan -- A summary for establishing a CGMP laboratory audit system -- Appendixes -- Example audit checklists: laboratory subelements -- Example template for an audit summary report -- Glossary of CGMP and audit system terms -- FDA compliance program guidance manual 7356.002 "Drug manufacturing inspections" -- 21 Code of U.S Federal Regulations parts 210 and 211 current good manufacturing practice regulations.
Record Nr. UNINA-9910841397903321
Bliesner David M  
Hoboken, N.J., : Wiley-Interscience, c2006
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Experiences of health maintenance organizations with pharmacy benefit management companies
Experiences of health maintenance organizations with pharmacy benefit management companies
Pubbl/distr/stampa [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 1997
Descrizione fisica 1 online resource (82 unnumbered pages) : illustrations
Soggetto topico Medicare
Medicaid
Health maintenance organizations - United States
Pharmaceutical services - United States
Pharmaceutical policy - United States
Pharmaceutical industry - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910707435003321
[Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 1997
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
FDA and the drug development process [[electronic resource] ] : how the agency ensures that drugs are safe and effective
FDA and the drug development process [[electronic resource] ] : how the agency ensures that drugs are safe and effective
Pubbl/distr/stampa Rockville, MD : , : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, , [2002]
Descrizione fisica 1 sheet : digital, PDF file
Collana Just the facts
Publication
Soggetto topico Drug development
Drugs - Testing
Pharmaceutical industry - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti FDA and the drug development process
Record Nr. UNINA-9910695574603321
Rockville, MD : , : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, , [2002]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995
FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995
Pubbl/distr/stampa Washington : , : U.S. Government Printing Office, , 1997
Descrizione fisica 1 online resource (iii, 55 pages)
Soggetto topico Medical instruments and apparatus industry - United States
Pharmaceutical industry - United States
Government paperwork - United States
Government paperwork
Medical instruments and apparatus industry
Pharmaceutical industry
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti FDA medical product approvals
Record Nr. UNINA-9910706250503321
Washington : , : U.S. Government Printing Office, , 1997
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
FDA-approved bargain drugs [[electronic resource] ] : generic products must meet high standards
FDA-approved bargain drugs [[electronic resource] ] : generic products must meet high standards
Edizione [Rev. Dec. 2003.]
Pubbl/distr/stampa Rockville, MD : , : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, , [2003]
Descrizione fisica 1 sheet : digital, PDF file
Collana Just the facts
Publication
Soggetto topico Generic drugs
Drugs - Testing
Pharmaceutical industry - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti FDA-approved bargain drugs
Record Nr. UNINA-9910695574703321
Rockville, MD : , : Dept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs, , [2003]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
FDAnews device daily bulletin
FDAnews device daily bulletin
Pubbl/distr/stampa Falls Church, Va., : Washington Business Information
Disciplina 615
Soggetto topico Pharmaceutical industry - United States
Food industry and trade - United States
Food industry and trade
Pharmaceutical industry
Soggetto genere / forma Periodicals.
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Record Nr. UNISA-996207885703316
Falls Church, Va., : Washington Business Information
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui